HIV antiviral drug resistance: Patient comprehension

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 7, 2010, Pages 816-826

  Racey, C Sarai ^a   Zhang, Wendy ^b   Brandson, Eirikka K ^b   Fernandes, Kimberly A ^b   Tzemis, Despina ^b   Harrigan, P Richard ^b,c   Montaner, Julio S G ^b,c   Barrios, Rolando ^b,c,d   Toy, Junine ^d   Hogg, Robert S ^a,b  

^a SIMON FRASER UNIVERSITY   (Canada)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

antiretroviral drug resistance; health literacy; HIV AIDS; patient comprehension

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ANTIVIRAL RESISTANCE; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HEALTH SERVICE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; TRUST;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRITISH COLUMBIA; COMPREHENSION; DRUG RESISTANCE, VIRAL; FEMALE; HEALTH EDUCATION; HIV; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 77954697900     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903431355     Document Type: Article

References (22)

1. Bangsberg, D.R., Acosta, E.P., Gupta, R., Guzman, D., Riley, E.D., Harrigan, P.R., et al. (2006). Adherenceresistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS, 20(2), 223-231.
2. Battaglioli-DeNero, A.M. (2007). Strategies for improving patient adherence to therapy and long-term patient outcomes. The Journal of the Association of Nurses in AIDS Care, 18(Suppl. 1), S17-S22.
3. BC Centre for Excellence in HIV/AIDS (2008). Drug treatment program update 2008. Vancouver, BC: Drug Treatment Program.
4. Dewalt, D.A., Berkman, N.D., Sheridan, S., Lohr, K.N., & Pignone, M.P. (2004). Literacy and health outcomes: A systematic review of the literature. Journal of General Internal Medicine: Official Journal of the Society for Research and Education in Primary Care Internal Medicine, 19(12), 1228-1239.
5. Gardner, E.M., Sharma, S., Peng, G., Hullsiek, K.H., Burman, W.J., Macarthur, R.D., et al. (2008). Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS, 22(1), 75-82.
6. Gross, R., Yip, B., Re, III., V.L., Wood, E., Alexander, C.S., Harrigan, P.R., et al. (2006). A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. The Journal of Infectious Diseases, 194(8), 1108-1114.
7. Hammer, S.M., Eron, Jr., J.J., Reiss, P., Schooley, R.T., Thompson, M.A., Walmsley, S., et al. (2008). Antiretroviral treatment of adult HIV infection 2008 recommendations of the international AIDS society-USA panel. Journal of the American Medical Association, 300(5), 555-570.
8. Hammer, S.M., Saag, M.S., Schechter, M., Montaner, J., Schooley, R.T., Jacobsen, D.M., et al. (2006). Treatment for adult HIV infection: 2006 recommendations of the international AIDS society-USA panel. Journal of the American Medical Association, 296(7), 827-843.
9. Hogg, R.S., Bangsberg, D.R., Lima, V.D., Alexander, C., Bonner, S., Yip, B., et al. (2006). Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. Plos Medicine, 3(9), e356.
10. Hogg, R.S., Yip, B., Kully, C., Craib, K.J., O'Shaughnessy, M.V., Schechter, M.T., et al. (1999). Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. Canadian Medical Association, 160(5), 659-665.
11. Holmes, W.C., & Shea, J.A. (1998). A new HIV/AIDStargeted quality of life (HAT-QoL) instrument: Development, reliability, and validity. Medical Care, 36(2), 138-154.
12. Lima, V.D., Hogg, R.S., Harrigan, P.R., Moore, D., Yip, B., Wood, E., et al. (2007). Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS, 21(6), 685-692.
13. Maggiolo, F., Airoldi, M., Kleinloog, H.D., Callegaro, A., Ravasio, V., Arici, C., et al. (2007). Effect of adherence to HAARTon virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PItreated patients. HIV Clinical Trials, 8(5), 282-292.
14. McCullagh, P. (1980). Regression models for ordinal data (with discussion). Journal of the Royal Statistical Society, Series B (Methodology), 42(2), 109-142.
15. Palella, Jr., F.J., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. The New England Journal of Medicine, 338(13), 853-860.
16. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21-30.
17. Pillay, D., Taylor, S., & Richman, D.D. (2000). Incidence and impact of resistance against approved antiretroviral drugs. Reviews in Medical Virology, 10(4), 231-253.
18. Stokes, M.E., Davis, C.S., & Koch, G.G. (2000). Categorical data analysis using the SAS system (2nd ed.). Cary, NC: SAS Institute.
19. Wolf, M.S., Davis, T.C., Arozullah, A., Penn, R., Arnold, C., Sugar, M., et al. (2005). Relation between literacy and HIV treatment knowledge among patients on HAARTregimens. AIDS Care, 17(7), 863-873.
20. Wood, E., Hogg, R.S., Yip, B., Harrigan, P.R., O'Shaughnessy, M.V., & Montaner, J.S.G. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4- cell count is 0.200 to 0.350-10(9) cells/L. Annals of Internal Medicine, 139(10), 810-816.
21. Yeni, P.G., Hammer, S.M., Carpenter, C., Cooper, D.A., Fischl, M.A., Gatell, J.M., et al. (2002). Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the international AIDS society-USA panel. Journal of the American Medical Association, 288(2), 222-235.
22. Yeni, P.G., Hammer, S.M., Hirsch, M.S., Saag, M.S., Schechter, M., Carpenter, C., et al. (2004). Treatment for adult HIV infection: 2004 recommendations of the international AIDS society- USA panel. Journal of the American Medical Association, 292(2), 251-265.